Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 30

Biotechnology

Highly pathogenic avian influenza confirmed on Bird Island, South Georgia – the first known cases in Antarctic
Biotechnology | Diagnostics | Infectious Disease | Influenza | Veterinary

Highly pathogenic avian influenza confirmed on Bird Island, South Georgia – the first known cases in Antarctic

On Oct. 23, 2023, the British Antarctic Survey (BAS) reported that Highly Pathogenic Avian Influenza (HPAI) had been…

Read More Highly pathogenic avian influenza confirmed on Bird Island, South Georgia – the first known cases in AntarcticContinue

U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
Biotechnology | Diagnostics | Infectious Disease | Influenza | Therapeutics | Vaccine

U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season

On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…

Read More U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 seasonContinue

FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
Biotechnology | FDA | Infectious Disease | Neurology | Vaccine

FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal

On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…

Read More FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcalContinue

Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK

On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…

Read More Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UKContinue

Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore

On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…

Read More Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in SingaporeContinue

APHIS announced partnership to improve early detection of emerging animal diseases
Agriculture | Biotechnology | Diagnostics | Disease | USDA

APHIS announced partnership to improve early detection of emerging animal diseases

On Oct. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced a new partnership between the National Bio…

Read More APHIS announced partnership to improve early detection of emerging animal diseasesContinue

Purdue nameed new pediatric cancer research center for the late Tyler Trent
Biotechnology | Diagnostics | Oncology | Therapeutics

Purdue nameed new pediatric cancer research center for the late Tyler Trent

On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…

Read More Purdue nameed new pediatric cancer research center for the late Tyler TrentContinue

Two fatal human influenza A/H5N1 (Bird Flu) virus infections reported in Cambodia
Biotechnology | Diagnostics | Infectious Disease | Influenza | Vaccine | WHO

Two fatal human influenza A/H5N1 (Bird Flu) virus infections reported in Cambodia

On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…

Read More Two fatal human influenza A/H5N1 (Bird Flu) virus infections reported in CambodiaContinue

New funding ensured 370 million children receive polio vaccinations in low-income countries
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO

New funding ensured 370 million children receive polio vaccinations in low-income countries

On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…

Read More New funding ensured 370 million children receive polio vaccinations in low-income countriesContinue

University of Wisconsin-Madison discovery revealed fragile X syndrome begins developing even before birth
Biotechnology | Life Science History | Neurology

University of Wisconsin-Madison discovery revealed fragile X syndrome begins developing even before birth

On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…

Read More University of Wisconsin-Madison discovery revealed fragile X syndrome begins developing even before birthContinue

California became first U.S. state to ban red dye No. 3
Biotechnology | Chemical | Disease | Oncology

California became first U.S. state to ban red dye No. 3

On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…

Read More California became first U.S. state to ban red dye No. 3Continue

Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threats
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threats

On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…

Read More Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threatsContinue

FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant

On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…

Read More FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variantContinue

Novavax 2023-2024 COVID-19 Vaccine  Authorized and Recommended for Use in the U.S.
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Vaccine

Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.

On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…

Read More Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.Continue

California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases
Biotechnology | Diagnostics | Disease | Neurology | Stem Cell | Therapeutics

California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases

On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…

Read More California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseasesContinue

U.S. National Science Foundation invested $35 million in future manufacturing
Biotechnology | NIH | Non-Profit Research | Therapeutics

U.S. National Science Foundation invested $35 million in future manufacturing

On Sept. 29, 2023, through the Future Manufacturing program, the U.S. National Science Foundation (NSF) announced targeted investments…

Read More U.S. National Science Foundation invested $35 million in future manufacturingContinue

FDA granted first marketing authorization for DNA test to assess predisposition for dozens of cancer types
Biotechnology | Diagnostics | FDA

FDA granted first marketing authorization for DNA test to assess predisposition for dozens of cancer types

On Sept. 29, 2023, the U.S. Food and Drug Administration (FDA) granted Invitae de novo marketing authorization for…

Read More FDA granted first marketing authorization for DNA test to assess predisposition for dozens of cancer typesContinue

California’s Stem Cell Agency invested $44 million to advance regenerative medicine research and manufacturing in California
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Stem Cell | Therapeutics

California’s Stem Cell Agency invested $44 million to advance regenerative medicine research and manufacturing in California

On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…

Read More California’s Stem Cell Agency invested $44 million to advance regenerative medicine research and manufacturing in CaliforniaContinue

Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine

On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…

Read More Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccineContinue

USDA provided more than $12 million in funding to control and prevent chronic wasting disease
Biotechnology | Diagnostics | Infectious Disease | Neurology | USDA | Veterinary

USDA provided more than $12 million in funding to control and prevent chronic wasting disease

On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA)  Animal and Plant Health Inspection Service (APHIS) announced…

Read More USDA provided more than $12 million in funding to control and prevent chronic wasting diseaseContinue

Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19

On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…

Read More Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19Continue

APHIS issued regulatory status review response for Ohalo Genetics potato
Agriculture | Biotechnology | FDA | USDA

APHIS issued regulatory status review response for Ohalo Genetics potato

On Sept. 26, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…

Read More APHIS issued regulatory status review response for Ohalo Genetics potatoContinue

Clinical trial of HIV vaccine began in United States and South Africa
Biotechnology | HIV | NIH | Non-Profit Research | Therapeutics | Vaccine

Clinical trial of HIV vaccine began in United States and South Africa

On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…

Read More Clinical trial of HIV vaccine began in United States and South AfricaContinue

National Institutes of Health clinical trial of universal flu vaccine candidate began
Biotechnology | Infectious Disease | Influenza | Nanotechnology | Vaccine

National Institutes of Health clinical trial of universal flu vaccine candidate began

On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…

Read More National Institutes of Health clinical trial of universal flu vaccine candidate beganContinue

WHO reported legionellosis deaths from Poland
Biotechnology | Disease | Therapeutics | WHO

WHO reported legionellosis deaths from Poland

On Sept. 14, 2023, the World Health Organization (WHO) reported that as of Sept. 11, 2023, a total…

Read More WHO reported legionellosis deaths from PolandContinue

Northwestern received $50 million to study life sciences using mathematics
Biotechnology

Northwestern received $50 million to study life sciences using mathematics

On Sept. 14, 2023, Northwestern University announced it had been awarded $50 million over five years from the…

Read More Northwestern received $50 million to study life sciences using mathematicsContinue

NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease
Biotechnology | Disease | Medicine | NIH | Therapeutics

NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease

On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…

Read More NIH awarded $50.3 million for ‘multi-omics’ research on human health and diseaseContinue

Moderna received U.S. FDA approval for updated COVID-19 vaccine
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna received U.S. FDA approval for updated COVID-19 vaccine

On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…

Read More Moderna received U.S. FDA approval for updated COVID-19 vaccineContinue

High levels of particulate air pollution associated with increased breast cancer incidence
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health

High levels of particulate air pollution associated with increased breast cancer incidence

On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…

Read More High levels of particulate air pollution associated with increased breast cancer incidenceContinue

European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
Biotechnology | Infectious Disease | Vaccine

European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older

On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…

Read More European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and olderContinue

Page navigation

Previous PagePrevious 1 … 28 29 30 31 32 … 158 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search